1993 Aug 15. [70, 71]. [Medline]. Antihepadnaviral, Reverse Transcriptase inhibitors, https://www.aasld.org/publications/practice-guidelines-0, Transfusion Requirements in Liver Transplantation, Imaging of Liver Transplantation Complications, http://www.cdc.gov/hepatitis/HBV/index.htm, http://www.who.int/wer/2011/wer8646/en/index.html, https://www.cdc.gov/std/tg2015/hepatitis.htm, http://guideline.gov/content.aspx?id=12812, http://www.medscape.com/viewarticle/825948, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K142891, http://www.hepatiq.com/fdaclearshepatiq.html, http://archives.niddk.nih.gov/haltctrial/displaypage.aspx?pagename=haltctrial/index.htm, http://guideline.gov/content.aspx?id=24043, http://www.medicalnewstoday.com/releases/146749.php, https://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm584820.pdf, https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM602537.pdf, https://www.medscape.com/viewarticle/888975, http://www.medscape.com/viewarticle/811629, http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm369846.htm, https://www.hhs.gov/hepatitis/blog/2016/11/21/fda-approves-vemlidy-tenofovir-alafenamide-for-chronic-hepatitis-b-in-adults.html, https://www.fda.gov/forpatients/illness/hepatitisbc/ucm408658.htm, http://www.gilead.com/news/press-releases/2016/11/us-food-and-drug-administration-approves-gileads-vemlidy-tenofovir-alafenamide-for-the-treatment-of-chronic-hepatitis-b-virus-infection, American Association for the Study of Liver Diseases, American Society for Gastrointestinal Endoscopy, International Liver Transplantation Society, American Society for Clinical Investigation. Hepatitis B virus. [64], ETV was associated with lactic acidosis in a study of 5 patients with liver failure who had Model for End-Stage Liver Disease (MELD) scores of greater than 20. 2014 Jul 1. [Medline]. 150(2):104-10. The discovery of the hepatitis viruses. [Full Text]. Ann Intern Med. [Medline]. [Medline]. 1989 Sep 14. 2006 Aug. 4(8):936-62.

Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities. Tenofovir is a nucleotide analogue (adenosine monophosphate) reverse transcriptase and HBV polymerase inhibitor.

(Conditional recommendation), For select patients older than 40 years, the AASLD suggests antiviral therapy in the setting of normal ALT levels, elevated HBV DNA (≥1,000,000 IU/mL), and significant necroinflammation or fibrosis on liver biopsy specimens. Furthermore, of the HBeAg-negative population, 64% experienced histologic improvement after receiving 10 mg of adefovir for 48 weeks, and 72% had normalized aminotransferase levels. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. [Medline]. Available at http://www.gilead.com/news/press-releases/2016/11/us-food-and-drug-administration-approves-gileads-vemlidy-tenofovir-alafenamide-for-the-treatment-of-chronic-hepatitis-b-virus-infection. [Medline]. J Natl Cancer Inst. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. 2004 May-Jun.

Available at http://guideline.gov/content.aspx?id=24043. 2000 Mar. 1999 Oct 21. 2009 Jun 16. In addition to interferon, antiviral therapy with lamivudine (3TC) has not only been shown to significantly increase the incidences of proteinuria remission and of HBeAg seroconversion but also cause a decline in levels of HBV-DNA in adult patients with HBV-related glomerulonephritis relative to controls. 50(Suppl 1):S10. [93]. 51(3):482-7. 2008 Sep. 2(3):263-83. Within the nucleocapsid are the hepatitis B core antigen (HBcAg) and precore hepatitis B e antigen (HBeAg), and on the envelope is the hepatitis B surface antigen (HBsAg). 46(3):420-6. It is a
The NIH also indicates that immediate therapy is not routinely indicated for patients who have the following

Hepatiq: Hepatic Quantitation. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. Prescribing Information, Brand names:  [85, 86] The development rate for the resistant mutations rtN236T and rtA181V has been estimated to be around 6%. Villeneuve JP, Durantel D, Durantel S, et al. Marcellin P, Heathcote EJ, Buti M, et al. Epivir, Generic name: tenofovir alafenamide systemic, For professionals: Clin Liver Dis. 2006 Mar 9. For HBeAg-negative patients with chronic hepatitis B disease, treatment can be administered when the HBV DNA is at or above 2,000 IU/mL (104 copies/mL) and the serum ALT is elevated (ALT levels >20 U/L for females; 30 U/L for males) for 3-6 months.